Despite its importance in reproductive biology and women's health, a detailed molecular-level understanding of the human endometrium is lacking. Indeed, no comprehensive studies have been undertaken to elucidate the important protein expression differences between the endometrial glandular epithelium and surrounding stroma during the proliferative and midsecretory phases of the menstrual cycle. We utilized laser microdissection to harvest epithelial cells and stromal compartments from proliferative and secretory premenopausal endometrial tissue and performed a global, quantitative mass spectrometry-based proteomics analysis. This analysis identified 1224 total proteins from epithelial cells, among which 318 were differentially abundant between the proliferative and secretory phases (q , 0.05), and 1005 proteins from the stromal compartments, 19 of which were differentially abundant between the phases (q , 0.05). Several proteins were chosen for validation by immunohistochemistry in an independent set of uterine tissues, including carboxypeptidase M, tenascin C, neprilysin, and ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3). ENPP3, which was elevated in epithelial glandular cells in the secretory phase, was confirmed to be elevated in midsecretoryphase baboon uterine lavage samples and also observed to have an N-linked glycosylated form that was not observed in the proliferative phase. This study provides a detailed view into the global proteomic alterations of the epithelial cells and stromal compartments of the cycling premenopausal endometrium. These proteomic alterations during endometrial remodeling provide a basis for numerous follow-up investigations on the function of these differentially regulated proteins and their role in reproductive biology and endometrial pathologies.
INTRODUCTION
The human endometrium is a dynamic tissue that undergoes rapid remodeling in response to steroid-driven changes in proliferation and differentiation. This monthly remodeling necessarily prepares the tissue for embryo implantation and yet, despite its importance in human biology and to common and prevalent female reproductive diseases, a comprehensive molecular understanding of what drives endometrial remodeling is far from complete. Furthermore, endometrial growth and differentiation are regulated by the dynamic interplay of the epithelial and stromal cell components, adding to the complexity of biomolecules likely to be differentially regulated during the secretory and proliferative phases of the menstrual cycle. Numerous transcript expression profiling studies of the uterine endometrium throughout the menstrual cycle have been performed using discovery-driven methods. These studies have revealed that the proliferative and secretory phases can be distinguished at a global level by transcript expression profiles, and, furthermore, that miRNA expression is also differentially regulated throughout the menstrual cycle [1] [2] [3] [4] [5] [6] . However, with the exception of the study by Kuokkanen et al. where biochemical fractionation was used to enrich for epithelial cells from endometrial biopsies [6] , interpreting molecular data from many of these studies can be complicated because the samples analyzed represent gross endometrial tissues with mixed and unknown contributions of stromal compartments and epithelial cell types. Discrete low-level molecular signals derived from epithelial cells or stromal compartments are likely to be masked by this tissue complexity, requiring further exploration to determine which endometrial component is expressing (or not) these signals. In addition, and perhaps more importantly, differential protein expression does not necessarily correspond to transcript abundance levels, necessitating direct protein-based analyses to comprehensively appreciate the biology of this complex organ.
Although numerous studies have examined global mRNA and miRNA expression in the endometrium, there have only been a few aimed at characterizing and/or distinguishing the proteome between different phases of the menstrual cycle, using peptide labeling (ICAT, iTRAQ) [7] [8] [9] or two-dimensional gel (2-DE) separation approaches [10, 11] . Recently the use of proteomics in reproductive biology has increased, and its use in developing biomarkers is thought to be critical if we are to progress in understanding the basis of disease and fertility defects [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Despite the opportunity for proteomics to add to our molecular understanding of organ-specific tissues, the cycling premenopausal human endometrium has not enjoyed such attention to date [21] .
We procured formalin-fixed, paraffin-embedded (FFPE) endometrial tissues from 30 premenopausal women from either the proliferative or the secretory phase of the menstrual cycle, harvested cells from both the epithelial (n ¼ 30, 15 each phase) and stromal (n ¼ 12, 6 each phase) compartments by laser microdissection (LMD), and utilized a label-free liquid chromatography-tandem mass spectrometry (LC-MS/MS) approach to identify differentially abundant proteins from these cellular components. This large-scale MS-based tissue proteomic analysis of the individual epithelial and stromal cell compartments of premenopausal endometrium identified numerous proteins associated with endometrial remodeling, many of which have not previously been described.
MATERIALS AND METHODS

Tissue Acquisition and Processing
Deidentified FFPE uterine tissue samples were obtained following institutional review board (IRB) approval from the Armed Forces Institute of Pathology. Endometrial tissues in the proliferative or secretory phases of menses were chosen for the study. Given that these cases were selected retrospectively from pathology archives, we did not have clinical annotation of a postovulatory date. Furthermore, detailed patient demographics (beyond age) and clinical reason for the surgical procedure were not available. Hematoxylin and eosin (H&E)-stained sections were, however, evaluated in detail by a board-certified gynecologic pathologist (C.Z.) to confirm the phase of menses. Ten-micrometer sections of each tissue were cut by microtome, placed onto LMD slides (Leica Microsystems) and laser microdissected to selectively capture (.95% purity) cells from the epithelial or stromal compartments (Supplemental Fig. S1 ; all supplemental data are available online at www. biolreprod.org). Laser-microdissected cells were collected directly into microcentrifuge tubes containing HPLC-grade water. Samples were brought to 100 ll with HPLC-grade water to which an additional 100 ll of 200 mM ammonium bicarbonate (AmBic), pH 7.6, 40% acetonitrile (ACN) was added for a final concentration of 100 mM AmBic, 20% ACN. Samples were incubated at 958C for 1 h followed by 2 h at 658C, after which porcine sequencing-grade trypsin (Promega) was added to achieve a final concentration of 1:50 enzyme:total protein and incubated overnight at 378C. Samples were dried by vacuum centrifugation, resuspended in 30 ll of 25 mM AmBic, and assayed for protein concentration using the bicinchoninic assay (results for epithelial cells and stromal compartments presented in Supplemental Tables S1 and S2 , respectively) (Pierce, Rockford, IL).
Liquid Chromatography-Tandem Mass Spectrometry
Each LMD-harvested endometrial tissue sample was analyzed in triplicate by LC-MS/MS on a nanoflow LC system (Easy-nLC II; ThermoFisher Scientific) coupled online with an LTQ Orbitrap Velos MS (ThermoFisher Scientific). Approximately 1 lg of endometrial tissue digest was consumed per LC-MS/MS technical replicate, equating to ;3 lg total peptide digest consumption per sample. The tissue digests were resolved on 100 lm I.D. 3 360 lm O.D. 3 20 cm long analytical capillary columns (Polymicro Technologies) slurry packed in house with 5 lm, 300 Å pore size C-18 silica-bonded stationary phase (Jupiter; Phenomenex). Following system equilibration, samples were loaded onto a 20-mm reversed-phase (C-18) precolumn (ThermoFisher Scientific) at 2 ll/min for 6 min with mobile phase A (0.1% formic acid in water). Peptides were eluted at a constant flow rate of 200 nl/min by development of a linear gradient of 0.33% mobile phase B (0.1% formic acid in ACN) per minute for 120 min and then to 95% mobile phase B for an additional 15 min. The column was washed for 15 min at 95% mobile phase B and then equilibrated with 100% mobile phase A prior to the next technical replicate or sample injection. The MS was configured to collect highresolution (R ¼ 60 000 at m/z 400) broadband mass spectra (m/z 375-1800) using the lock mass feature for the polydimethylcyclosiloxane ion generated in the electrospray process (m/z 445.12002). Mass spectrometric conditions were set as follows: electrospray voltage, 1.7 kV; no sheath and auxiliary gas flow; capillary temperature, 2008C; S-Lens RF level, 69%. The ion selection threshold for the Orbitrap (MS) was set at 1 3 10 6 with a maximum ion accumulation time of 500 ms. The 20 most abundant ions were selected for MS/ MS in the high-pressure linear ion trap with the following settings: ion threshold, 5000; minimum intensity, 3000; maximum ion accumulation time, 25 ms; activation time, 10 ms. Dynamic exclusion (60 sec) was utilized to minimize redundant selection of peptides for MS/MS.
Data Analysis
Tandem mass spectra were searched against the UniProt human protein database (downloaded 21 February 2014; 68 756 sequences) from the Universal Protein Resource (www.uniprot.org) using Mascot Daemon/Server (v.2.3.2/ v.2.3; Matrix Science Inc.) using the automatic decoy search option. The data were searched with a precursor mass tolerance of 10 ppm and a fragment ion tolerance of 0.6 Da. Methionine oxidation (15.99492) was set as a dynamic modification and a maximum of two missed cleavages was allowed. Peptide spectral matches (PSMs) were filtered using an ion score cutoff of 33, resulting in a false peptide discovery rate of less than 1%. PSMs whose sequence mapped to multiple protein isoforms were grouped as per the principle of parsimony [22] . The peptide spectral match and protein identification metrics (average number of identifications and their standard deviation and relative standard deviation) for each sample were calculated across all samples in each sample set as well as in each phase-specific sample set showing no significant (P . 0.05) bias in peptide or protein identifications between the two phases for either the epithelial or stromal samples (results for epithelial cells and stromal compartments presented in Supplemental Tables S1 and S2, respectively). Protein abundance differences across all samples within each sample set were determined by spectral counting, where the total PSMs identified for a given protein reflected overall abundance [23, 24] . The data were further filtered, requiring at least one PSM in two thirds of the samples within a subset for each comparison, and spectral counts were normalized by the lowest total spectral count value sample in the comparison set. For each comparison, normal proliferative epithelium versus secretory epithelium and normal proliferative stroma versus normal secretory stroma, significance (P values) and false positives (q values) were estimated using the R package ''q value'' [25] . The q value for a protein estimates the proportion of false positives among the subset of proteins with P values at least as small as the P value for that protein. The q value method accounts for multiple comparisons and consistently estimates the Bayesian posterior probability of false positives. All proteomics results are available at the PRoteomics IDEntifications Archive (http://www.ebi.ac.uk/ pride/archive/).
For comparisons of our data with other published results, UniProt accessions were directly compared between data sets where applicable. Swiss-Prot accession IDs from Chen et al. [10] were compared directly to the UniProt reference accession in our database. Protein GI (GenInfo Identifier) accessions were converted to UniProt accessions using the Database for Annotation, Visualization and Integrated Discovery (DAVID, v6.7; http:// david.abcc.ncifcrf.gov/home.jsp) utility and all potential matched UniProt accessions (multiple were identified for many of the input accessions) were used to compare and identify common proteins in this study with other publicly available data sets.
Immunohistochemistry
Deidentified archival FFPE endometrial tissue specimens (see Supplemental Table S3 for patient demographic summary) were obtained following IRB approval (Spectrum Health Hospital System). H&E-stained sections were evaluated by a board-certified pathologist for diagnosis and endometrial dating. Thin (4-lm) tissue sections containing human endometrium from the proliferative or secretory phase for each case were cut by microtome onto glass microscope slides, deparaffinized with xylene, and rehydrated in ethanol, and antigen retrieval was performed by boiling the slides in a pressure cooker in 1:1000 antigen unmasking solution (Vector Lab, Inc.). Endogenous peroxidase was blocked using 3% hydrogen peroxide and nonspecific binding was inhibited with normal goat serum at a dilution of 1:10 (Vector Lab, Inc.). Sections were incubated overnight at 48C with the following antibodies: carboxypeptidase M (CPM), diluted 1:300 (Sigma-Aldrich, St. Louis, MO); tenascin C (TNC), diluted 1:500 (Epitomics); neprilysin (MME), diluted 1:100 (Leica); and ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3), diluted 1:500 (Sigma-Aldrich). After washing, sections were incubated in biotinylated immunoglobulin G (IgG) secondary antibody (Vector Lab, Inc.) at ambient temperature, followed by incubation in streptavidin horseradish peroxidase conjugate, 1:100 (Invitrogen), at ambient temperature. Immunohistochemical (IHC) reactions were developed with a peroxidase substrate kit (DAB; Vector Lab, Inc.), counterstained with hematoxylin, HOOD ET AL. dehydrated, and mounted. Negative controls were processed using the same procedure, where PBS was used in place of the primary antibody. Additional negative controls included isotype-specific IgG secondary antibodies incubated as above on the same panel of endometrial samples. Expression of CPM, TNC, MME, and ENPP3 was assessed quantitatively using ImageJ software [26] . The DAB-specific area and mean gray value within that area relative to hematoxylin staining were calculated for each protein in each sample. The area represented expression extent and the mean gray value indicated expression intensity for all three factors. A large value of the area and small mean gray value indicated strong expression, where a small value of the area and large mean gray value indicated decreased expression. An unpaired t-test was used to compare the IHC-determined expression difference of each target protein between the two phases of endometrium where P , 0.05 was considered statistically significant.
Uterine Lavage
Uterine lavage samples were collected from cycling female olive baboons (Papio anubis) at midsecretory and proliferative phases of the menstrual cycle in accordance with the Michigan State University institutional guidelines for the care and use of laboratory animals. Menstrual cycle phase from baboons was determined from serum estradiol levels and perineal tumescence. For lavage, 5 ml of Hanks balanced salt solution (Gibco, Life Technologies) was infused transcervically into the uterine cavity via an endometrial cannula, recovered by aspiration, centrifuged at 800 3 g to remove cellular debris, and stored in aliquots at À208C [27] . Uterine lavage samples were dialyzed overnight using 2000 MWCO centrifugal filters (Thermo-Scientific), lyophilized, and resuspended in RIPA buffer. Protein samples were quantified by the Bradford assay and subjected to immunoblotting as described below. Nglycanase (Prozyme) treatments were performed as previously described [28] . 
RESULTS
Proteins Identified in the Epithelial and Stromal Compartments
LMD was used to selectively harvest (.95% estimated enrichment) glandular epithelial cells from 30 premenopausal endometrial tissue specimens, equally divided among proliferative and secretory phases of the menstrual cycle. A total area of ;9 mm 2 of tissue from each 8-lm thin section, representing ;63 nl of total tissue volume, was harvested by LMD from each endometrial tissue thin section and prepared using our heat-induced, trypsin-mediated digestion protocol that resulted in an expected peptide recovery of ;1 lg/mm 2 (Supplemental Table S1 ) [29] . The tissue digests were each analyzed in triplicate by high-resolution LC-MS/MS from which 1224 proteins were identified across all samples, 318 of which were differentially abundant between the two phases of the menstrual cycle (q , 0.05) (Supplemental Table S4 ). Proteins identified from glandular epithelial cells included the progesterone receptor B (PGR), expressed preferentially during the proliferative phase, and glycodelin A (PAEP), expressed in the secretory phase of the menstrual cycle (Fig. 1) [30, 31] . In addition, CPM, palladin (PALLD) and minichromosome maintenance complex component 6 (MCM6) (Fig. 1A,   FIG. 1 . Differential expression of proteins between the secretory and proliferative endometrium identified from the endometrial glandular epithelium. Box-and-whisker plots illustrating the PSM-derived differential abundance of PGR, CPM, PALLD, MCM6, DBN1, and TNC from the proliferative (P) phase (A) and PAEP, ENPP3, PPL, HGD, and PIGR from the secretory (S) phase (B) of the menstrual cycle identified from the endometrial glandular epithelium.
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proliferative phase) and ENPP3, periplakin (PPL), homogentisate 1,2-dioxygenase (HGD) and polymeric immunoglobulin receptor (PIGR) (Fig. 1B, secretory phase) were also significantly differentially abundant in the glandular epithelium in the proliferative as compared to the secretory phase. A network enrichment analysis (Ingenuity Pathways Analysis) was performed and cellular growth and proliferation was identified as the most significantly enriched pathway (P ¼ 1.00 3 10
À17
), involving 145 of the 318 significantly altered proteins identified from epithelial cells from the proliferative as compared to the secretory endometrium (Supplemental Table  S5 ).
Stromal compartments from six each of proliferative and secretory endometrial tissue specimens were similarly LMD harvested, digested, and analyzed in triplicate by highresolution LC-MS/MS, from which 1005 proteins were identified, 19 of which were differentially abundant between the proliferative or secretory stromal compartments (q , 0.05) (Supplemental Table S6 ). Among the most differentially abundant proteins between the proliferative and secretory phase in the stromal samples were apolipoprotein C, isoform III (APOC3), which was more abundant in the proliferative phase, and MME and collagen alpha-2, isoform IV (COL4A2), which were elevated in the secretory phase (Fig. 2 ). In agreement with previous studies, PGR, PAEP, and TNC have been identified previously in the endometrium and recapitulate the results from our proteomics approach [32] [33] [34] [35] [36] [37] . Interestingly, TNC and drebrin 1 (DBN1), also previously identified in proliferative endometrium, were observed to be significantly increased in abundance in the proliferative phase in both the epithelial and stromal components. A network enrichment analysis (Ingenuity Pathways Analysis) was performed and Tissue Development was identified as the most significantly enriched pathway (P ¼ 2.24 3 10 À6 ); however, caution should be exercised in the interpretation of these pathway enrichment results, as only 19 proteins were significantly altered in the stromal samples harvested from the proliferative as compared to the secretory endometrium (Supplemental Table S7 ).
IHC Validation in Independent Tissue Sample Cohort
IHC was used to confirm the proteomics-derived phasespecific expression of CPM, TNC, MME, and ENPP3 in an independent set of seven each of proliferative and secretory endometrial tissue samples (Fig. 3) . The significant differential expression of CPM, TNC, and MME (Fig. 3, right) as observed in the proteomics data was confirmed by IHC. However, the abundance difference for ENPP3 between the proliferative and secretory phases was not statistically different, a finding that did not agree with our proteomics data, although the samples exhibited endometrial glandular epithelia specific staining.
Evaluation of ENPP3 in Olive Baboon Uterine Lavage Fluid
Immunoblot analysis of uterine lavage samples from olive baboons revealed an increase in ENPP3 abundance during the midsecretory phase, in agreement with our proteomics data (Fig. 4A) . Interestingly, an additional immune-reactive band larger than the predicted ENPP3 molecular weight was evident in the uterine lavage specimens collected from baboons in the secretory phase (Fig. 4A, lanes 4-6) . We hypothesized that this band may represent a glycosylated form of ENPP3. To test this hypothesis, we digested lavage samples with N-glycanase, which resulted in the loss of this higher-molecular-weight band compared with the untreated lavage sample (Fig. 4B) , suggesting that ENPP3 is N-glycosylated in the secretory phase of the menstrual cycle.
DISCUSSION
The uterus is a dynamic organ that alters the expression of prostaglandins, cytokines, and growth factors in response to hormonal signaling. Contemporary methods of discovery proteomics provide an opportunity to more definitively identify proteins associated with the proliferative and secretory phases of menses. Here we utilized a tissue compartment-specific proteomics approach and identified multiple differentially expressed proteins in the proliferative and secretory phases of the menstrual cycle. We and others have shown that there is no significant difference in the MS-based proteomics results generated from fresh-frozen versus FFPE tissues [24, 29, [38] [39] [40] [41] , and in the present case, where LMD was utilized to dissect discrete cell populations from the tissue microenvironment, formalin fixation is advantageous, as the morphology of the tissue microenvironment is preserved to a greater extent as compared to frozen specimens.
In this investigation, determination of proliferative and secretory phase was made based on the histological assessment of the glandular epithelium and stroma. Although the proliferative endometrium cannot be further subcategorized (or ''dated''), criteria for ''dating'' the secretory endometrium according to the luteal phase do exist. However, the application of dating criteria, particularly from a clinical relevance standpoint, is controversial, and we did not further date or subcategorize the secretory endometrial specimens. As a result, it is likely that the secretory endometrial specimens contained early secretory stromal compartments (prepseudodecidualized) and later secretory stromal compartments (pseudodecidualized), and may therefore have had different protein expression. However, a total of six secretory specimens were included; it is unlikely that detailed analysis of the secretory specimens categorizing the stromal compartments as prepseudodecidualized or pseudodecidualized would have significantly affected the results.
Compared to prior studies that used tissue-based proteomics of the premenopausal endometrium, our study had limited overlap with previous reports of proteins differentially expressed between the proliferative and secretory phases of menses. In the initial publication from DeSouza et al. using   FIG. 3 . IHC detection of select differentially expressed proteins in the endometrium. A) IHC detection of CPM, TNC, MME, and ENPP3 in the proliferative and secretory phases of the menstrual cycle. B) Quantitative results from grading the IHC stain intensity for CPM, TNC, MME, and ENPP3 from an independent set of endometrial tissue specimens in the proliferative (P, n ¼ 7) and secretory (S, n ¼ 7) phases of the menstrual cycle. Significant differences were observed for CPM, MME, and TNC, but not for ENPP3. Magnification 320.
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whole-tissue homogenates from proliferative and secretory tissue samples, cleavable ICAT labeling was combined with offline fractionation, resulting in the identification of 119 proteins; however, only five were considered significantly different between the proliferative and secretory phases [8] . A comparison of our data with these results showed an overlap of 11 proteins with our significantly differentially abundant epithelial data (q , 0.05), 1 concordantly greater in the proliferative phase and 7 in the secretory. Although we did not identify any proteins that matched the five differential proteins from DeSouza et al. [8] , a few of interest in this study, namely PAEP and PIGR, were observed to have similar trends in abundance. In a pair of studies using 2-DE MALDI and wholeendometrial-tissue homogenates, one study found 196 differentially abundant protein spots (P , 0.05), of which 76 were positively identified [10] , and the other positively identified 194 proteins from 215 spots selected, of which 49 were differentially expressed [11] . In comparing our glandular epithelial proteomics results with those of Chen et al., 14 proteins were similarly differential between the proliferative and secretory phases (q , 0.05), among which two were similarly elevated in the proliferative phase whereas nine were correspondingly elevated in the secretory phase [10] . All three proteins that Chen et al. validated by IHC were also observed in our epithelial data comparison having similar trends in expression between the proliferative and secretory endometrium. None of the significantly altered proteins identified by Chen et al. matched our proteomics data from the endometrial stromal compartment. In comparing our data with those of Rai et al., 147 proteins were commonly identified between their study and our glandular epithelial (75 proteins) and stromal (72 proteins) proteomics, 6 of which were found commonly altered between the proliferative and secretory phases between their data and our glandular epithelial results (q , 0.05) [11] . No significantly altered proteins from Rai et al. were found to be altered between the proliferative and secretory phase in our proteomic analysis of endometrial stroma [11] .
It is not surprising that a number of proteins not previously described were identified in our study. Previous investigators used whole-endometrial-tissue homogenates, whereas the present investigation employed LMD to selectively harvest cells from the glandular epithelium and the stromal compartments of the endometrium. Previous studies of the endometrium have confirmed paracrine and autocrine processes that appear to be compartment specific in the endometrial lining, limiting the clinical applicability of prior investigations [42] . The proliferative phase of the menstrual cycle is characterized by an increased amount of stroma in comparison to the epithelial cells, whereas the secretory phase has a comparatively lower amount of stroma. By using whole-tissue homogenates, these compartments are pooled, resulting in underrepresentation of total epithelial protein in the proliferative-phase tissue and likewise a lower overall stromal aspect to the secretory-phase tissue.
Our findings are further strengthened by verification of three differentially expressed proteins in an independent sample set of uterine tissue specimens using IHC. These included CPM, which has a potential role in cell signaling and tissue remodeling [43] [44] [45] ; MME, a stroma-specific protein used in determining the pathologic diagnosis of endometrial stromal sarcoma as opposed to other sarcoma [46] [47] [48] ; and ENPP3, in which we noted strong uterine expression in the Human Protein Atlas resource [49] [50] [51] . Ectonucleotide pyrophosphatase/phosphodiesterase 3, a member of a family of proteins with ATPase activity involved in the hydrolysis of extracellular nucleotides, is a transmembrane protein classed with other cell-surface ectoATPases that modulate complex interactions with nucleotides and their breakdown products [52] [53] [54] . Recently, ENPP3 has been shown to regulate N-acetylglucosaminyltransferase Gn-T-IX, which suggests that ENPP3 may alter the glycosylation state of many proteins [55] . An examination of tissue sections immunostained for ENPP3 indicated strong glandular luminal surface staining; in some samples with retained luminal secretions, we noted very strong staining in the secretion (Fig. 3, left) . Because the luminal contents are often retained in LMD workflows, but not necessarily so in all IHC sections, we chose to further evaluate the expression patterns of ENPP3.
Immunoblot analysis of uterine lavage samples from olive baboons staged at either the proliferative or the midsecretory phase confirmed that ENPP3 is elevated in the secretory phase, as identified from our proteomic analysis. Interestingly, an additional higher-molecular-weight species was observed in the ENPP3 immunoblot of the uterine lavage samples collected from olive baboons in the secretory phase. Although no alternatively spliced or alternate variant of ENPP3 that could account for the increased-molecular-weight protein product in the secretory samples has been annotated, the protein does possess 10 potential N-linked glycosylation consensus sites. We treated secretory-phase uterine lavage samples with Nglycanase, which resulted in loss of the additional immuneresponsive band, suggesting that this additional band is an Nglycosylated version of ENPP3. Previous studies with the rat homologue, NPP3, demonstrated that although N-glycosylation is not necessary for apical localization, it is important for efficient intracellular trafficking and plays a further important role in stabilizing NPP3 once the protein is localized to the cell surface [56] . 
HOOD ET AL.
ENPP3 is expressed at low levels in several human tissues, including the lung, kidney, and digestive tract, and is also a cluster of differentiation marker (CD203c) expressed on basophils [50, 57, 58] . The highest levels of expression are seen in the uterine epithelium and in the seminal vesicles, pointing to its likely importance in reproductive biology [50, 57] . Recently the various ecto-nucleases were surveyed in human endometrium, and ENPP3 was found to be specifically elevated in the secretory phase of the menstrual cycle [59] . The increased secretory expression of ENPP3 was recently described to be blunted in a progestin-resistant manner from the eutopic endometrium from women with endometriosis. Here we show that that N-glycosylated ENPP3 secretion into the uterine lumen is dramatically increased in the midsecretory phase. This result, along with the observation that ENPP3 secretion is diminished from the endometrium of endometriosis patients, suggests a potential role for this protein in fertility [60] . Taken together, these data suggest that N-glycosylated ENPP3 may be a candidate biomarker for the normal midsecretory phase of the endometrium.
Our understanding of normal and diseased endometrium has been hampered by a lack of compartment-specific omicsrelated analyses aimed at characterizing the proliferative and secretory phases of the menstruating endometrium. This paucity of information motivated the global quantitative proteomic analysis of the epithelial and stromal compartments of the cycling endometrium described in this study. This study identified many novel proteins differentially expressed throughout the menstrual cycle, several of which were confirmed by IHC, including ENPP3, a secretory-phaseexpressed protein that also undergoes a phase-specific Nglycosylation. The proteomic alterations identified in this study provide the basis for numerous mechanistic investigations to detail the functional role and importance of these differentially regulated proteins in endometrial biology. Indeed, phasespecific protein expression will critically inform the prioritization of biomarkers for validation for diseases such as endometrial cancer or endometriosis, where the hypothesis of progesterone resistance has emerged as a predominant mechanism regulating gene/protein expression in these lesions [60, 61] .
